share_log

Why Timber Pharmaceuticals Shares Are Getting Hammered

Why Timber Pharmaceuticals Shares Are Getting Hammered

為什麼木材製藥的股票會遭受重創
Benzinga Real-time News ·  2022/10/03 11:24

Timber Pharmaceuticals Inc (NASDAQ:TMBR) shares are trading lower by 20.09% to $0.09 Monday morning after the company announced a $1.3 million registered direct offering.

木材製藥公司納斯達克(Temasek Holdings:TMBR)股價週一早盤下跌20.09%,至0.09美元,此前該公司宣佈進行130萬美元的註冊直接發行。

What Else?

還有什麼?

The closing of the offerings is expected to occur on or about October 3rd, subject to the satisfaction of customary closing conditions.

在滿足慣例成交條件的情況下,此次發行預計將於10月3日左右結束。

The company intends to use the net proceeds from the offerings for working capital and general corporate purposes.

該公司打算將發行所得資金淨額用於營運資金和一般企業用途。

See Also: This Solar Company's 5-Year Return Beats Tesla, Bitcoin, Ethereum, Ford, Apple, Microsoft And Amazon

另見:這家太陽能公司的5年回報率超過了特斯拉、比特幣、以太、福特、蘋果、微軟和亞馬遜

According to data from Benzinga Pro, Timber Pharmaceuticals has a 52-week high of $0.93 and a 52-week low of $0.08.

根據Benzinga Pro的數據,Timber PharmPharmticals的52周高點為0.93美元,52周低點為0.08美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論